Cargando…
Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study
To reach the goals of the Global Hepatitis Elimination 2030 program, Indonesia is now preparing a new regulation for hepatitis B vaccinations for adult population. This study aimed to determine the factors influencing vaccine uptake for hepatitis B in the adult population, and identify barriers to,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967628/ https://www.ncbi.nlm.nih.gov/pubmed/36851280 http://dx.doi.org/10.3390/vaccines11020398 |
_version_ | 1784897312382779392 |
---|---|
author | Machmud, Putri Bungsu Führer, Amand Gottschick, Cornelia Mikolajczyk, Rafael |
author_facet | Machmud, Putri Bungsu Führer, Amand Gottschick, Cornelia Mikolajczyk, Rafael |
author_sort | Machmud, Putri Bungsu |
collection | PubMed |
description | To reach the goals of the Global Hepatitis Elimination 2030 program, Indonesia is now preparing a new regulation for hepatitis B vaccinations for adult population. This study aimed to determine the factors influencing vaccine uptake for hepatitis B in the adult population, and identify barriers to, and facilitators of, hepatitis B vaccination programmes. An explanatory sequential mixed methods design was implemented in this study. We conducted a survey involving 893 participants in the general population followed by 14 in-depth interviews with health providers. The survey found that only 15% (95% confidence interval 13–18%) of participants received at least one dose of the hepatitis B vaccine. Factors associated with vaccine uptake were, living in Yogyakarta compared to living in Aceh, having secondary and higher education compared to primary education, working as a health worker compared to working in other sectors, and having health insurance that covered hepatitis B vaccination compared to not having such health insurance. Our qualitative study also identified several barriers to the adult hepatitis B vaccination programme in Indonesia such as the high cost of vaccination, lack of vaccine availability in certain areas, limited human resources to implement the hepatitis B vaccination programme, and the ineffective dissemination of hepatitis B vaccination. This study highlights that accessibility and affordability of vaccinations are important determinants of vaccination uptake that should be taken into account when planning vaccination campaigns. |
format | Online Article Text |
id | pubmed-9967628 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99676282023-02-27 Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study Machmud, Putri Bungsu Führer, Amand Gottschick, Cornelia Mikolajczyk, Rafael Vaccines (Basel) Article To reach the goals of the Global Hepatitis Elimination 2030 program, Indonesia is now preparing a new regulation for hepatitis B vaccinations for adult population. This study aimed to determine the factors influencing vaccine uptake for hepatitis B in the adult population, and identify barriers to, and facilitators of, hepatitis B vaccination programmes. An explanatory sequential mixed methods design was implemented in this study. We conducted a survey involving 893 participants in the general population followed by 14 in-depth interviews with health providers. The survey found that only 15% (95% confidence interval 13–18%) of participants received at least one dose of the hepatitis B vaccine. Factors associated with vaccine uptake were, living in Yogyakarta compared to living in Aceh, having secondary and higher education compared to primary education, working as a health worker compared to working in other sectors, and having health insurance that covered hepatitis B vaccination compared to not having such health insurance. Our qualitative study also identified several barriers to the adult hepatitis B vaccination programme in Indonesia such as the high cost of vaccination, lack of vaccine availability in certain areas, limited human resources to implement the hepatitis B vaccination programme, and the ineffective dissemination of hepatitis B vaccination. This study highlights that accessibility and affordability of vaccinations are important determinants of vaccination uptake that should be taken into account when planning vaccination campaigns. MDPI 2023-02-09 /pmc/articles/PMC9967628/ /pubmed/36851280 http://dx.doi.org/10.3390/vaccines11020398 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Machmud, Putri Bungsu Führer, Amand Gottschick, Cornelia Mikolajczyk, Rafael Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study |
title | Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study |
title_full | Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study |
title_fullStr | Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study |
title_full_unstemmed | Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study |
title_short | Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study |
title_sort | barriers to and facilitators of hepatitis b vaccination among the adult population in indonesia: a mixed methods study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967628/ https://www.ncbi.nlm.nih.gov/pubmed/36851280 http://dx.doi.org/10.3390/vaccines11020398 |
work_keys_str_mv | AT machmudputribungsu barrierstoandfacilitatorsofhepatitisbvaccinationamongtheadultpopulationinindonesiaamixedmethodsstudy AT fuhreramand barrierstoandfacilitatorsofhepatitisbvaccinationamongtheadultpopulationinindonesiaamixedmethodsstudy AT gottschickcornelia barrierstoandfacilitatorsofhepatitisbvaccinationamongtheadultpopulationinindonesiaamixedmethodsstudy AT mikolajczykrafael barrierstoandfacilitatorsofhepatitisbvaccinationamongtheadultpopulationinindonesiaamixedmethodsstudy |